Open Access
Open access
Science advances, volume 7, issue 22

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

Sham Nambulli 1, 2
Yufei Xiang 3
Natasha L. Tilston-Lunel 1, 2
Linda J. Rennick 1, 2
Zhe Sang 3, 4
William B. Klimstra 1, 2, 5
Douglas Reed 1, 5
Yi Shi 3, 4
1
 
Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA.
2
 
Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA.
3
 
Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA.
5
 
Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Publication typeJournal Article
Publication date2021-05-28
Journal: Science advances
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor13.6
ISSN23752548
Multidisciplinary
Abstract

Aerosol delivery of an ultrapotent nanobody efficiently prevents and treats SARS-CoV-2 infection.

Top-30

Citations by journals

1
2
3
4
5
6
Frontiers in Immunology
6 publications, 5.26%
Nature Communications
5 publications, 4.39%
Viruses
4 publications, 3.51%
Nanoscale
3 publications, 2.63%
Veterinary Pathology
2 publications, 1.75%
International Journal of Molecular Sciences
2 publications, 1.75%
Frontiers in Microbiology
2 publications, 1.75%
Pharmaceutical Research
2 publications, 1.75%
Cell Reports
2 publications, 1.75%
Acta Pharmaceutica Sinica B
2 publications, 1.75%
iScience
2 publications, 1.75%
Small Methods
2 publications, 1.75%
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 1.75%
eLife
2 publications, 1.75%
Antiviral Research
2 publications, 1.75%
Nature Chemical Biology
1 publication, 0.88%
Biochemical Society Transactions
1 publication, 0.88%
Nanomaterials
1 publication, 0.88%
Frontiers in Drug Discovery
1 publication, 0.88%
Frontiers in Nuclear Medicine
1 publication, 0.88%
Biomedicines
1 publication, 0.88%
Nature
1 publication, 0.88%
MRS Bulletin
1 publication, 0.88%
BioDrugs
1 publication, 0.88%
Scientific Reports
1 publication, 0.88%
Communications Biology
1 publication, 0.88%
Cell Discovery
1 publication, 0.88%
Communications Medicine
1 publication, 0.88%
Bioengineering
1 publication, 0.88%
1
2
3
4
5
6

Citations by publishers

5
10
15
20
25
30
Elsevier
27 publications, 23.68%
Springer Nature
19 publications, 16.67%
Frontiers Media S.A.
11 publications, 9.65%
Cold Spring Harbor Laboratory
11 publications, 9.65%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 7.89%
Wiley
5 publications, 4.39%
American Chemical Society (ACS)
4 publications, 3.51%
Royal Society of Chemistry (RSC)
3 publications, 2.63%
Taylor & Francis
3 publications, 2.63%
SAGE
2 publications, 1.75%
Public Library of Science (PLoS)
2 publications, 1.75%
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 1.75%
eLife Sciences Publications
2 publications, 1.75%
American Society for Microbiology
2 publications, 1.75%
Portland Press
1 publication, 0.88%
Cambridge University Press
1 publication, 0.88%
American Society for Biochemistry and Molecular Biology
1 publication, 0.88%
EMBO press
1 publication, 0.88%
American Institute of Mathematical Sciences (AIMS)
1 publication, 0.88%
Hindawi Limited
1 publication, 0.88%
University of Nis
1 publication, 0.88%
Dove Medical Press
1 publication, 0.88%
The Royal Society
1 publication, 0.88%
Spandidos Publications
1 publication, 0.88%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.88%
5
10
15
20
25
30
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Nambulli S. et al. Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses // Science advances. 2021. Vol. 7. No. 22.
GOST all authors (up to 50) Copy
Nambulli S., Xiang Y., Tilston-Lunel N. L., Rennick L. J., Sang Z., Klimstra W. B., Reed D., Crossland N. A., Shi Y., Duprex W. P. Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses // Science advances. 2021. Vol. 7. No. 22.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1126/sciadv.abh0319
UR - https://doi.org/10.1126/sciadv.abh0319
TI - Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
T2 - Science advances
AU - Nambulli, Sham
AU - Xiang, Yufei
AU - Tilston-Lunel, Natasha L.
AU - Rennick, Linda J.
AU - Sang, Zhe
AU - Klimstra, William B.
AU - Reed, Douglas
AU - Crossland, Nicholas A.
AU - Shi, Yi
AU - Duprex, W. Paul
PY - 2021
DA - 2021/05/28 00:00:00
PB - American Association for the Advancement of Science (AAAS)
IS - 22
VL - 7
SN - 2375-2548
ER -
BibTex
Cite this
BibTex Copy
@article{2021_Nambulli,
author = {Sham Nambulli and Yufei Xiang and Natasha L. Tilston-Lunel and Linda J. Rennick and Zhe Sang and William B. Klimstra and Douglas Reed and Nicholas A. Crossland and Yi Shi and W. Paul Duprex},
title = {Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses},
journal = {Science advances},
year = {2021},
volume = {7},
publisher = {American Association for the Advancement of Science (AAAS)},
month = {may},
url = {https://doi.org/10.1126/sciadv.abh0319},
number = {22},
doi = {10.1126/sciadv.abh0319}
}
Found error?